Compound 2194
Identifiers
- Canonical SMILES:
COc1cc(ccc1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1
- IUPAC name:
4-[2-(4-hydroxy-3-methoxyphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide
- InChi:
InChI=1S/C18H16N4O4S/c1-26-17-12-14(7-10-16(17)23)21-20-13-5-8-15(9-6-13)27(24,25)22-18-4-2-3-11-19-18/h2-12,23H,1H3,(H,19,22)
- InChiKey:
NNVWBPGOBVMGDY-UHFFFAOYSA-N
External links
![]() 136174615 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 384.09 g/mol | |||
HBA | 8 | |||
HBD | 2 | |||
HBA + HBD | 10 | |||
AlogP | 3.78 | |||
TPSA | 110.44 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7068 | Sulfasalazine | DB00795 | |
0.6887 | Sulfapyridine | DB00891 | |
0.5441 | Sulfamethoxypyridazine | DB13773 | |
0.5319 | Sulfaethoxypyridazine | DB11462 | |
0.5246 | Sulfameter | DB06821 | |
0.5245 | ABT-751 | DB12254 | |
0.5197 | Sulfaquinoxaline | DB11464 | |
0.5088 | Sulfadiazine | DB00359 | |
0.5000 | Sulfachlorpyridazine | DB11461 | |
0.4895 | N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE | DB07944 | |
0.4833 | Sulfaperin | DB13320 | |
0.4797 | AMG-131 | DB05490 | |
0.4737 | Sulfadoxine | DB01299 | |
0.4688 | Sulfamethazine | DB01582 | |
0.4636 | Sulfadimethoxine | DB06150 |